Long Grove intros single-pack for generic Hemabate

Long Grove Pharmaceuticals is offering the first and only commercially available single-pack for carboprost tromethamine injection, which is the generic of Pfizer’s Hemabate.

[Read more: Long Grove Pharmaceuticals launches generic Kenalog-40]

“We are thrilled to offer the first single-pack presentation of carboprost tromethamine to continue to provide flexibility to hospitals, pharmacy departments and patients,” said Dan Robins, president and CEO of Long Grove. “Utilizing our team’s extensive experience in supply chain management and commercial insight, we remain focused on bringing even more flexibility to the market through product presentations like this.”